Standaard boekhandel marleen - handelsschool aalst - adriaens eddy
Octreotide
1
Reactions 1420 - 22 Sep 2012 Octreotide Diarrhoea: case report A 55-year-old man with thyroid stimulating hormone- secreting pituitary adenoma began treatment with IM octreotide [Sandostatin LAR] 30mg monthly and developed diarrhoea [time to reaction onset and outcome not stated]. He underwent adenomectomy and then remained asymptomatic, with normalisation of his free thyroid hormone levels. Author comment: "Octreotide is an effective but expensive therapy and may be associated with adverse effects." Gehmacher U, et al. Thyroid stimulating hormone-secreting pituitary adenoma: A rare, diagnostically challenging, and potentially curable disease. Austrian Journal of Clinical Endocrinology and Metabolism 3: 10, 2010 [abstract] - Austria 803076908 1 Reactions 22 Sep 2012 No. 1420 0114-9954/10/1420-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
Transcript of Octreotide
Reactions 1420 - 22 Sep 2012
Octreotide
Diarrhoea: case reportA 55-year-old man with thyroid stimulating hormone-
secreting pituitary adenoma began treatment with IMoctreotide [Sandostatin LAR] 30mg monthly and developeddiarrhoea [time to reaction onset and outcome not stated].He underwent adenomectomy and then remainedasymptomatic, with normalisation of his free thyroidhormone levels.
Author comment: "Octreotide is an effective butexpensive therapy and may be associated with adverseeffects."Gehmacher U, et al. Thyroid stimulating hormone-secreting pituitary adenoma: Arare, diagnostically challenging, and potentially curable disease. Austrian Journalof Clinical Endocrinology and Metabolism 3: 10, 2010 [abstract] -Austria 803076908
1
Reactions 22 Sep 2012 No. 14200114-9954/10/1420-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
